Avid Bioservices Inc (CDMO)

[itsabouttime]

I think different design in terms of ECOG 0 & 1 (healthier patients) and ARMS.

Patients will be randomized into 1 of 2 treatment arms

2. PPHM salvages the data sufficiently to have the FDA approve a phase III of the same design as the phase II